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Summary 
T  cell development in the thymus requires the establishment of stable interactions with cell- 
selecting elements such as the  cortical epithehum followed by a regulated movement of se- 
lected progenitors to the medulla. Cell adhesion and migration are mediated by integrins in a 
number of biological systems though little is known regarding their function in the thymus. 
We demonstrated previously that immature CD31~  l~ double positive human thymocytes 
adhere avidly to FN via the integrin, VLA4. We now demonstrate that the interaction of ma- 
ture CD3hiCD69  hi thymic subsets  with FN triggers migration rather than firm adhesion. Mi- 
gration requires the engagement of  VLA4 in cooperation with VLA5 and both receptors regu- 
late the persistence and directionality of movement. While migration capability is linked to 
maturation state,  ligand concentration determines the efficiency of migration. In fact, FN and 
the alternatively sphced CS1 site are predominant in the thymic medulla, suggesting an instruc- 
tive role of this ECM protein in vivo.  Our studies identify a novel VLA4 and VLA5/FN- 
mediated pathway likely to be involved in regulating cell traffic between the cortex and me- 
dulla of the thymus. Moreover, the data provides evidence that VLA4 exists  in at least  two 
functional states at distinct stages ofT cell development. While different states of VLA4 activa- 
tion have been described on cell lines, this represents the first evidence supporting a biological 
significance for this integrin property. 
p ositioning of developing thymocytes within the thymic 
cortex and  medulla  as well as  the  regulation  of their 
ability to move from one region to another are crucial to 
T cell differentiation. Thus a stable interaction with cortical 
epithelial cells facihtating the recognition of MHC/peptide 
complexes is a prerequisite for the positive selection of im- 
mature double positive T  cells (1). In fact, there is evidence 
that positive selection within the cortex is limited by con- 
tact with these selecting elements (2,  3)  underscoring the 
importance of migratory events leading T  cell progenitors 
to  the  epithehum.  Subsequent  events  of maturation,  in- 
cluding negative selection, appear to occur in the medulla 
involving bone marrow-derived antigen-presenting cells as 
well as a phenotypically distinct medullary epithelium (4). 
Implicit in  these  compartment-specific events is  the  pro- 
grammed detachment of developing thymocytes from the 
cortical epithelium and the  regulated movement of those 
committed to the mature single positive phenotype to the 
medulla. While much has been learned about the function 
of the T  cell receptor (TCPQ and the costimulatory mole- 
cules, CD4 and CD8, these molecules cannot directly me- 
diate stable cell-cell adhesion or migration. In contrast, the 
role  of interactions mediated by integrin adhesion mole- 
cules  expressed  by  thymocytes with  extracellular matrix 
(ECM) 1 proteins  such  as  fibronectin  (FN)  in  thymocyte 
motihty, has not been elucidated. 
FN is a major structural component of the thymus (5, 6), 
but  its  function  in  thymic  physiology  is  presently  un- 
known. Nevertheless, extensive evidence supports a pivotal 
role of FN in cell adhesion and migration in other biologi- 
cal systems (7). FN has been shown to regulate the migra- 
tion and accumulation of activated cells  during acute and 
chronic inflammation (8, 9), wound healing (10), tissue re- 
generation (7), and tumor metastases  (11). Likewise, during 
embryogenesis, FN provides the adhesive cues necessary to 
promote and guide the migration of neural crest and meso- 
1Abbreviations used in  this paper: CFN, cellular fibronectin; cx, cortex; 
ECM, extracellular  matrix; FN, fibronectin;  LC, lower chamber; m, me- 
dulla; UC, upper chamber; VN, vitronectin. 
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ing sites have been characterized within the FN molecule, 
including the RGDS sequence,  located within  the central 
region of FN, and the CS1 sequence, at the carboxy-termi- 
hal end (13,  14).  The primary cell surface receptors recog- 
nizing such sites  are members of the integrin gene super- 
family (15).  Two integrin receptors capable of binding FN 
are expressed on human thymocytes: VLA5 (ot5131, CD49e/ 
CD29), recognizing the RGDS site (16), and VLA4 (c~4131, 
CD49d/CD29)  recognizing  the  CS1  site  (17,  18).  These 
integrins  can  mediate  either  stable  adhesion  or  the  more 
complex function of migration. 
The adhesive or migratory response of cells to FN can be 
regulated by various mechanisms including changes in the 
local production of FN, alternative splicing of its cell bind- 
ing sites and modulation ofintegrin expression or function. 
For example, the loss of FN production is a feature of some 
malignant cells (7,  11). Alternative splicing of the FN tran- 
script may involve the CS1  site and generates a number of 
functionally different FN isoforms (19,  20).  Production  of 
FNs highly enriched for CS1  occurs during embryonal de- 
velopment suggesting  a  key role  of this  sequence  in  cell 
motility and/or growth  (21).  FN variants lacking CS1  fail 
to support migration of melanoma cells  (22).  In addition, 
preferential splicing and expression of this motif is present 
at  the  synovial endothelium  of patients  with  rheumatoid 
arthritis (23) and the inhibition of binding to this sequence 
abrogates leukocyte cell adhesion and migration into local 
tissues  (24,  25).  Similarly, the addition  of the type III re- 
peats EIIIA and EIIIB by alternative splicing,  distinguishes 
cellular forms of FN from plasma FN  (26).  Expression of 
these EIIIA+ and/or EIIIB+ forms of FN correlates with 
higher embryonal cell motility (27).  Finally,  adhesion  can 
be modulated through changes in VLA4 and VLA5 expres- 
sion or function (28, 29). In particular, an important feature 
of these integrins is that they may exist on a cell's surface in 
several states  of activation with  different  avidities  for FN 
(30-33)  providing  a  strategy  by  which  cells  can  rapidly 
modulate the strength of interactions with this ligand. 
We have previously characterized the differential expres- 
sion of several integrins on human thymic subsets and dem- 
onstrated that VLA4 is highly  expressed on most thymo- 
cytes, whereas VLA5 is upregulated on single positive ceils 
(34,  35). We demonstrated that VLA4 expressed by imma- 
ture CD31~176  double positive thymocytes is constitu- 
tively activated as measured by its  ability to mediate firm 
attachment to  FN  (34).  In contrast,  mature CD3hiCD69 hi 
CD4  and  CD8  single positive as well as  the  CD4+CD81~ 
transition  subsets  fail  to  adhere  to  this  substrate.  Interest- 
ingly,  VLA4  expression  is  similar  on  both  adherent  and 
non-adherent populations,  suggesting that the function  of 
this  receptor rather than  its  levels of expression is modu- 
lated at different stages ofT cell maturation. 
In the present study we hypothesized that the functional 
modulation of VLA4, resulting in a loss of firm adhesion at 
the transition between the double and single positive stage, 
may  actually  enable  the  migration  of more  mature  thy- 
mocytes, thereby providing a  mechanism by which  posi- 
tively selected  thymocytes move  frorn  the  cortex  to  the 
medulla. Therefore, we developed a migration assay to de- 
termine the ability of human thymocytes to migrate on FN 
in vitro. We demonstrate that CD3  hi thymic subsets display 
a high migratory activity on FN which is ligand concentra- 
tion-dependent,  whereas  most  CD3  l~  double  positive 
thymocytes are stationary. However, at relatively high con- 
centrations  of ligand we can demonstrate the  recruitment 
of a  CD3intCD69 hi  double  positive population  indicating 
that there are differences in migratory eflqciency within the 
double positive subset that also correlate with activation or 
maturation  stage.  Interestingly,  immunofluorescence  mi- 
croscopy revealed  a  differential  distribution  of both  FN- 
and the CSl-binding site between the cortex and medulla 
of the thymus, suggesting that FN has an instructive role in 
the control of thymocyte motility in vivo imparted by the 
structural  organization  of this  integrin  ligand.  Finally,  we 
demonstrate that thymocyte migration is mediated by the 
cooperative engagement of both VLA4 and VLA5 integrins 
on the CS1 and RGDS sequences of FN and that informa- 
tion determining the speed and direction of migration can 
be signalled by these interactions.  Based on these data we 
propose  a  new  model  integrating  the  regulation  of thy- 
mocyte migration  mediated by VLA4  and  VLA5  on  FN 
with the current knowledge of T  cell development in the 
thymus. 
Materials  and Methods 
Tissue and Cell Preparation.  Fragments of human thymus were 
obtained from 1 month to 7-yr-old children undergoing  elective 
cardiac surgery  at the  Children's  Hospital  (San Diego,  CA).  A 
single cell suspension of thymocytes was prepared by gently teas- 
ing the  tissue on 60-p,m stainless steel meshes into ice-cold se- 
rum-free HBSS. After washing, cells were resuspended in serum- 
free HBSS and viability determined by trypan blue exclusion. Only 
preparations with viability I>98% were used. 
Antibodies and Reagents.  Monoclonal antibodies used for triple 
immunofluorescence  and flow cytometry analysis of human thy- 
mocytes were: RPE-conjugated anti-CD4 (clone 13B8.2; Immu- 
notech, Westbrook, ME), FITC-conjugated anti-CD8 (clone.B9.11; 
Irmnunotech), Cy-ChromeVM-conjugated  anti-CD3  (clone HIT3a; 
PharMingen,  San  Diego,  CA),  FITC-conjugated  anti-CD69 
(Becton  Dickinson,  San Jose,  CA),  RPE-conjugated anti-HLA 
A,B,C (clone G46-2.6,  PharMingen),  and matching, fluoro-con- 
jugated,  isotype controls. Monoclonal antibodies specific for hu- 
man plasma FN  (clone  FN-15)  or cellular FN  (clone  FN-3E2) 
were obtained  as ascites from Sigma (St. Louis, MO). The anti- 
FN Mab clone 333 was a kind gift ofDrs. S. Akiyama and K. Ya- 
mada. Antibodies  used as secondary reagents were biotin-conju- 
gated goat F(ab)2 fragments specific for mouse IgG (Caltag, San 
Francisco,  CA)  or mouse IgM (Cappel,  Durham,  NC).  FITC- 
conjugated  streptavidin  (SA) was  obtained from GIBCO BRL 
(Gaithersberg,  MD).  Lissamine rhodamine-conjugated  SA  was 
from Jackson  Laboratories  (West  Grove, PA).  Purified  anti-~5 
mAb  (clone  SAM1) was  obtained  from  Inmmnotech.  Anti- 
human o~4 mAb (clone HP2/1) was either  purchased  from Im- 
rnunotech  or was a kind gift  of Dr.  Sanchez-Madrid  (Madrid, 
Spain). The anti-c~4137 antibody, ACT-l, was a kind gift of Drs. 
Newman and Ringler (LeukoSite  Inc.,  Cambridge,  MA).  Puri- 
fied  anti-human CD54  (ICAM-1) mAb (clone  P5F5) blocking 
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raised against the CS1 peptide sequence of FN (clone 90.45) were 
obtained from Cytel Corporation (San Diego, CA). A  synthetic 
molecule resembling the CS1 sequence ofFN (phenylacetic acid- 
Leu-Asp-Phe-d-Pro-amide, compound  P96)  and  a  scrambled 
version  (phenylacetic  acid-Asp-Leu-Phe-d-Pro-amide, compound 
P66) were also provided by Cytel. The ICs0 (50% inhibition con- 
centration) in vitro of the CS1  peptide for VLA-4-mediated ad- 
hesion to FN is 0.2-0.5 ~M (9). Purified human plasma FN was 
obtained from Sigma. Purified human vitronectin (VN) was from 
Promega  (Madison,  WI).  The  40-  and  120-kD  chymotryptic 
fragments of FN were obtained from GIBCO BILL. 
Immunofluorescence and Flow Cytometry.  Three-color immuno- 
fluorescence staining of human thymocytes was performed by in- 
cubating the cells in HBSS/2% FCS/0.05% NaN  3 in the presence 
ofRPE, FITC and Cy-Chrome conjugated specific antibodies or 
species and isotype-matched controls for 30  rain at  4~  After 
washing, samples were analyzed on a FACScan  |  (Becton Dickin- 
son,  San Jose, CA) equipped with Lysis II software. A  live cell 
gate was created by excluding cell debris and non-viable cells on 
forward angle and side light scatter and analysis performed on at 
least 10,000 events. The live gate was confirmed in some experi- 
ments by propidium iodide staining. 
Cell Migration Assay.  Cell migration assays were  carried out 
in Transwell  TM  culture chambers (Costar 3415, Cambridge, MA) 
using the same ECM coating conditions and culture medium as 
described in our previous report (34).  The 3-~m porous mem- 
brane separating the upper from the lower chamber of the Tran- 
swells  TM  was precoated (10  ~g/ml in PBS)  on both sides  with 
VN,  intact  FN  or chymotryptic fragments of FN overnight at 
4~  After  rinsing  with  PBS,  non-specific binding  sites  were 
blocked by  incubation  for  30  min  at  37~  in  PBS/1%  heat- 
treated BSA (80~  20 rain). Thymocytes prepared in serum-free 
HBSS  were  seeded  in  serum-free  AIMV  culture  medium 
(GIBCO BRL) in the upper chamber of the Transwells  TM at 3 ￿ 
106 cells/well and cultured at 37~  in a 5% CO2 humidified in- 
cubator. At various time points, thymocytes retained in the upper 
chamber and  those  migrated to  the  lower chamber were  har- 
vested, counted and stained for flow cytometry. In the migration 
inhibition studies, thymocytes were pre-incubated for 15 rain at 
4~  in the presence of saturating concentrations of anti-VLA4, 
anti-VLA5, anti-ICAM-1 mAbs or control mouse IgG and added 
to the upper chamber of the Transwells  TM  without further wash- 
ing. Alternatively, thymocytes were incubated in the presence of 
the VLA-4 specific P96 blocking peptide or P66 control peptide. 
Blocking antibodies and peptides were present at a final concen- 
tration of 10  txg/ml during culture.  Results were  expressed as 
percent of migrating cells in the control cultures. Statistical analy- 
sis was  performed  using  the  Wilcoxon test  (StatView;  Abacus 
Concepts  Inc., Berkeley, CA).  In the experiments assessing the 
proliferative status  of migrating and non-migrating thymocytes, 
triplicate  cultures  were  pulsed  for  8  h  with  2  b~Ci/well  of 
[3H]thymidine  (New  England  Nuclear,  Dupont,  Wilmington, 
DE).  Cells were then harvested onto glass fiber filters  using the 
cell  harvester  96  Mach  III  (Tomtec  Inc,  Orange,  CT)  and 
counted in a scintillation counter (model 1450 Microbeta; Wallac 
Oy, Turku, Finland). 
Immunofluorescence Microscopy.  8-1*m  frozen  thymic  sections 
were air-dried for 2 h at room temperature, fixed in absolute eth- 
anol for 2 min at -20~  and blocked overnight at 4~  in PBS/ 
1% heat-inactivated BSA containing 20 I~g/ml of purified goat Ig 
(Jackson Immunoresesearch Laboratories, West Grove, PA). Sec- 
tions were incubated for 1 h at room temperature in the presence of 
a 1:400 dilution of either anti-FN or anti-CFN ascites or 1 I*g/ml 
of purified anti-CS1 mAb (IgM). Control slides were incubated 
in the presence of an anti-thyroglobulin ascites or normal mouse 
IgM  (Dako,  Glostrup,  Denmark).  After extensive  washings  in 
PBS/0.1% BSA/0.05% Tween 20, binding of primary mAbs was 
detected by sequential incubations with a biotin-conjugated goat 
anti-mouse IgG or goat anti-mouse [gM followed by SA-Lissa- 
mine  Rhodamine.  Slides were  mounted  in  Gel-Mount  (Bio- 
meda,  Foster City,  CA)  and  analysed for  specific fluorescence 
(Olympus Microscope, Tokyo, Japan). 
Time-lapse Video Microscopy.  Thymocytes were allowed to mi- 
grate for 8 h  through Transwell  TM  membranes coated with FN 
(0.2 Ixg/ml) in medium containing either Dil or DiO fluorescent 
carbocyanins (1 i~g/ml; Molecular Probes Inc., Eugene, OR). This 
treatment results in labeling ofthymocytes with a red (DiI) or green 
fluorescence (DiO). At the end of the incubation, DiO-labeled 
thymocytes retained in the upper chamber and DiI-labeled cells 
which had migrated to the lower chamber were harvested. DiI- 
and DiO-labeled cells were mixed at a 1:2 ratio to account for the 
lower  frequency  of migrating  cells  present  among  thymocytes 
from the upper chamber. Cells were then resuspended in AIM V 
medium supplemented with 20 mM Hepes, seeded on top of a 
glass bottom  microwell (Mat  Tek  Corporation, Ashland, MA) 
coated with FN (0.2  p~g/ml) and cultured at 37~  on a tempera- 
ture-controlled microscope stage.  Cell migration was recorded at 
one frame/70 s for ~2.5  h  with a Zeiss Axiovert M35  micro- 
scope equipped with a confocal attachment (MRC1024; BioRad, 
Hercules, CA) and all images were stored on optical disks. In the 
antibody inhibition experiments, the control mAb was added at 
the initiation of the first 2.5 h period. The blocking mAb (10 btg/ 
ml) were then added to the same cells and migration observed for 
an additional 2.5  h.  Cell migration tracks were measured using 
NIH Image (version 1.59b9, Bethesda, MD). 
Results 
Purified FN Supports Migration of Human Thymocytes.  To 
assess whether FN can serve as an adhesive ligand for thy- 
mocyte migration we developed a TransweU assay system. 
Freshly isolated thyrnocytes were plated in the upper cham- 
ber onto the porous membrane coated with purified FN or 
control substrates. The number and phenotype of the cells 
migrating from  the  upper  to  the lower compartment  was 
then determined by cell counting and flow cytometry anal- 
ysis at various times of culture.  Fig.  1 A  compares thymo- 
cyte migration after 8  h  of culture  on  membranes  coated 
with 10 Izg/ml of either FN, VN, or BSA. Previous exper- 
iments titrating the coating concentration of these proteins 
demonstrated that  5-10  Izg/ml was  optimal for migration 
(data not shown).  FN supported an eight- to  ninefold in- 
crease  in  the  number  of migrating thymocytes  (~10%  of 
the  cells plated in  the  upper  chamber)  as  compared with 
the migration on BSA or VN-coated membranes.  In cul- 
tures  continued  up  to  48  h,  a  greater  number  of thy- 
mocytes (up to 22% of the cells plated in the upper cham- 
ber)  migrated  to  the  lower  chamber  across  FN-coated 
membranes.  To  exclude the possibility that  cell prohfera- 
tion  during  the  8-h  assay  contributed  to  the  increased 
number  of cells counted  in the lower chamber  after FN- 
mediated  migration,  [3H]thymidine  incorporation  assays 
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(3)< 106) were cultured in serum-free conditions in the upper chamber of 
TransweUs  TM  whose porous membranes were  pre-coated  (10  p.g/ml) 
with either FN or VN. The membranes of the control wells (BSA) were 
coated with the blocking solution, 1% heat-inactivated BSA. Number 
of cells which migrated across the membrane to the lower chamber of 
the Transwell  TM  within an 8-h culture period are shown. Bars represent 
mean + SD of  triplicate samples. FN but not VN supports thymocyte mi- 
gration. (B) Thymocytes were cultured for 8 h on membranes pre-coated 
with the indicated concentrations  of  FN. Number of cells which migrated 
to the lower chamber within this time period are shown. Each  point rep- 
resents the mean +  SD of triplicate samples. Thymocytes migrate on FN 
in a ligand concentration-dependent fashion. 
were  performed.  The  data  (n  =  3)  expressed  as  cpm per 
cell  revealed  the  following:  cultures  of total  thymocytes, 
mean  +  SE  =  6.8  (-+0.3)  ￿  10-3; upper chamber cells  = 
7.3  (-+0.5)  ￿  10-3; lower chamber cells  =  5.9  (-+2.0)  ￿ 
10 -3. Thus, the migrating thymocytes (lower chamber) are 
not significantly enriched for proliferating  cells.  As shown 
in  Fig.  1  B,  increasing  numbers  of thymocytes  were  re- 
cruited to migrate in response to higher coating concentra- 
tions  of FN.  These  data  indicate  that  FN  supports  thy- 
mocyte migration in a concentration-dependent fashion. 
Differential Migratory  Capability  of Double  Positive and  Sin- 
gle  Positive  Thymocytes  as  a  Function  of Ligand  Concentra- 
tion.  Flow  cytometric  analysis  of the  migrating  cells  re- 
vealed that different thymic subsets  migrated as a function 
of different concentrations of membrane-bound FN (Fig. 2). 
In these  experiments  all  results  are  depicted  for cells  ana- 
lyzed in the live gate which consistently represented  >80% 
of the total cells.  Thymocytes migrating across membranes 
coated with the lowest concentrations of FN (0.0016--0.04 
p,g/ml)  were  enriched  for CD4  and  CD8  single  positive 
subsets  as  well  as  for  the  CD4+CD8  l~ transition  cells  as 
compared to the unseparated  thymocytes (Fig.  2,  B vs A). 
Conversely,  relatively  few  double  positive  cells,  mostly 
CD41~176  were seen among migrating thymocytes. No- 
tably,  CD4+CD8 +  double  positive  thymocytes  represent 
the major population remaining in the upper compartment 
of the TranswelF  M (Fig.  2  C).  Consistent with their more 
mature  CD4/CD8  phenotype,  migrating  cells  also  ex- 
pressed  higher levels  of CD3,  CD69  and MHC  class  I  as 
compared to those remaining in the upper chamber (Fig. 2, 
B vs C) or the unseparated thymocytes (Fig. 2 A). In terms 
of absolute numbers, thymocytes displaying a migratory ac- 
tivity  on  the  lowest  coating  concentrations  of FN  repre- 
sented --,1-2% of the input population. 
Membranes  coated with relatively higher concentrations 
of FN  (0.2-5  I.tg/ml)  substantially  enhanced  the  absolute 
numbers  of migrating  CD3  hi  single  positive  and  CD3  hl 
double  positive  thymocytes  (Fig.  2  B).  However,  the  re- 
cruitment  of an  increasing proportion  of CD3  int  cells  ex- 
pressing intermediate  levels of CD69 and MHC  class I was 
also observed. Three-color immunostaining for CD4, CD8 
and CD69 or MHC  I followed by selective gating on such 
CD69  int  and  MHC  Iint cells  demonstrated  that  they  were 
primarily  double  positive  cells  (data  not  shown).  In  these 
cultures,  migrating cells represented  2.9-10%  of the  origi- 
nal  input  population.  Nonetheless,  we  calculated  that  the 
number  of migrating  single  positive  cells  was  30-40%  of 
the  single  positive  cells  in  the  input  population,  whereas 
the  total  of migrating  double  positive  thymocytes  repre- 
sented only 5-7% of the input double positive population. 
Most  thymocytes  retained  in  the  upper  chamber  of the 
Transwells  TM were CD31~  + and expressed very 
low levels of CD69  (Fig.  2  C). With the exception of the 
cells  cultured  on membranes  coated with  the highest  con- 
centration  of FN  (5  btg/ml),  the migrating cells  expressed 
slightly lower levels of VLA4 but higher levels of VLA5 as 
compared to the  non-migrating subsets  (Table  1).  Finally, 
migration assays performed to assess the phenotype  of mi- 
grating  subsets  as  a  function  of different  times  in  culture 
demonstrated  that  CD3  hi  thymocytes  migrated  at  earlier 
time points than CD3  int double positive cells.  Furthermore, 
while ,',,60% of single positive cells still remained in the up- 
per chamber after 8 h, if we extended the incubation to 48 h 
essentially all the single positive cells  migrated to the lower 
chamber (data not shown). These results also suggest a heter- 
ogeneity of migration efficiency in this mature population. 
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Figure 2.  Differential migratory activity of single positive and double positive thymocytes on FN. Thymocytes (3 ￿  106) were cultured for 8 h in ei- 
ther uncoated plastic tissue culture wells or on Transwell  TM  membranes coated with 0.0016, 0.04, 0.2,  1, or 5 p,g/ml of FN, respectively. At the end of 
the culture period, cells in the plastic wells (A), those which migrated to the lower chamber (B), and those which remained in the upper chamber of the 
Transwells  TM  (C), were harvested and analysed for the expression of CD4, CD8, CD3, CD69, and MHC class I by flow cytometry. Three-color immu- 
nofluorescence was performed using anti-CD4-RPE, anti-CD8-FITC, and anti-CD3-CyChrome mAbs. Levels of  CD69 and MHC I were assessed using 
anti-CD69-FITC and anti-MHC class I-RPE mAbs. The CD4/CD8 dot plots relative to each experimental condition are shown and the percentage of 
single positive and double positive cells indicated in each quadrant. Quadrants were set to comprise the staining given by control antibodies in the left 
lower quadrant. Data represent the analysis of 10,000 events collected within a live gate comprising >80% of  the total cells in all experimental conditions. 
The absolute number of viable cells recovered at the end of the culture period is given in parentheses on top of each dot plot. Histograms represent the 
fluorescence intensities of CD3, CD69 and MHC class I expression. The vertical bars within the histograms were set using the profdes of the Total Thy- 
mocytes (A) to define cell subpopulations with low, intermediate and high levels of  antigen-specific fluorescence. The fluorescence intensity with the iso- 
type-control antibodies is contained within the region defined as low. 
219  Crisa et al. Table  1.  Expression  of VLA4 and VLA5 on Migratory and Non-migratory Thymocytes 
FN (I.~g/ml)*  0.0016  0.04  0.2  1  5 
VLA4  Upper chamber cells  294 +  11  327  -  0  316 -+ 11  316 -+ 11  310  +  16 
Lower chamber cells  246  -  26  249 -+ 4  245  -+ 0  255 -  27  365  4- 13 
VLA5  Upper chamber cells  27 -+ 2  29 -+ 0  25  -+ 5  24 +  0.5  30 -+ 1.5 
Lower chamber cells  45 +  3  45 +  0.5  42 +  5.5  40 +  1.5  31  +  2 
Migratory (lower  chamber) and non migratory (upper chamber) thymocytes cultured under conditions identical to the experiment depicted in Fig. 2, 
were harvested from the upper and lower chamber of the Transwells  TM  stained for the expression of  VLA4 and VLA5 and analyzed by flow cytome- 
try. Values are mean + SD of  medians of fluorescence intensity (log units). Median of  fluorescence intensity in control samples was < 10 log units. 
*  Coating concentrations of FN on Transwell's  TM porous membranes. 
The  data  demonstrate  that  a  substantial  fraction  of the 
most mature CD3 hi single positive and double positive cells 
migrate on FN more efficiently than the relatively less ma- 
ture CD3  int double positive cells,  the latter subset being re- 
cruited  only  at  higher  coating  concentrations  of FN.  In 
contrast,  we  could  not  demonstrate  the  migration  of the 
CD31~ cells  under  any  condition  tested.  This  observation 
suggests that  thymocyte motility on FN is  determined  by 
the  differentiation  state  of the  cells.  Moreover,  migration 
triggered by cellular interactions  with  FN is further regu- 
lated by the  amount  of ligand  present  in  the  extracellular 
environment. 
Distribution of FN,  CFN and the CS1  Peptide Sequence of 
FN within the Human  Thymus.  Differences  in  the  distri- 
bution of FN within tissues as well as the alternative splic- 
ing  of certain  adhesive  sequences,  particularly  CS1,  are 
mechanisms by which FN may regulate  cell adhesion and 
migration in vivo. Double positive and single positive thy- 
mocytes, displaying distinct adhesive (34) and migratory ca- 
pability on FN in vitro,  are positioned in vivo within  the 
cortex and the medulla of the thymus, respectively. There- 
fore, we examined the possibility that these two compart- 
ments of the thymus present a differential distribution and/or 
alternative  splicing of endogenous  FN.  The  expression  of 
the plasma form of FN, its alternatively spliced isoform cel- 
lular FN (CFN) and the distribution of the CS1 peptide se- 
quence, representing the primary FN binding site of VLA4, 
was determined by in situ immunofluorescence. 
As shown in Fig. 3, staining of frozen sections of human 
thymus  with  plasma  FN-  or  CFN-specific  antibodies  re- 
vealed a similar distribution  of the two isoforms predomi- 
nantly  in  the  corticomedullary junction  and  the  medulla 
(m).  In the medulla,  FN appears to be organized in either 
fibrillar structures or large irregular patches, the latter likely 
to comprise clusters  of stromal cells.  In contrast,  relatively 
few FN-containing fibers are present in the cortex (cx). In- 
terestingly,  immunostaining for the  CS1  peptide  sequence 
revealed a unique pattern  as compared to the  distributions 
of either the plasma form of FN or CFN. CS1 staining high- 
lights the medulla,  sharply defining the boundary with the 
surrounding cortex. Moreover, the medullary CSl-specific 
sequences  are  distributed  in  a  reticular  fashion  which  at 
higher magnification was confirmed to mark the pericellu- 
lar matrix around thymocytes. 
Thus  the  medulla  of the  human  thymus  provides  resi- 
dent thymocytes with a microenvironment highly enriched 
for FN and specifically the alternatively spliced CS1  bind- 
ing site for VLA4. In contrast,  the cortex of the thymus is 
relatively poor in  FN  and  CS1  sequence.  The  concentra- 
tion  of FN  regulates  the  migration  of thymic  subsets  in 
vitro. Therefore, the differential expression of FN between 
the cortex and medulla suggests that FN may also regulate 
the migration of cortical and medullary thymocytes in vivo. 
Migration of Thymocytes on FN Involves the Engagement of 
VLA4 and  VLA5.  The  integrins  VLA4  and  VLA5  have 
been implicated in both the adhesion and migration of var- 
ious cell types on FN (22, 36, 37). We have demonstrated 
that VLA4, but not VLA5, mediates  firm adhesion  of hu- 
man thymocytes to FN (34).  To investigate whether these 
integrins  mediated  thymocyte  migration,  we  performed 
migration  assays  in  the  presence  of blocking anti-cl4  and 
anti-el5 antibodies  or peptides.  As shown in Fig. 4 A, thy- 
mocyte  migration  was  significantly inhibited  by blocking 
both VLA4 and VLA5, simultaneously (~75% inhibition as 
compared to  control cultures,  P  =  0.06,  n  =  4).  In con- 
trast, blocking either VLA4 or VLA5 alone had little or no 
effect respectively. This result was confirmed by the inabil- 
ity of the  c14131-specific  blocking peptide,  P96,  to inhibit 
migration (Fig. 4). 
Thymocytes  express  high  levels  of the  integrin,  0tL[32 
(LFA-1). The binding of this integrin to ICAM-1 has been 
involved in the adhesion and migration of peripheral blood 
T  lymphocytes and T  cell lines (38, 39). We tested the ef- 
fects  of  blocking  LFA-1/ICAM-1  interactions  on  thy- 
mocyte migration with  an anti-ICAM-1  mAb.  These  ex- 
periments  failed  to  demonstrate  any  inhibition  (data  not 
shown).  Indeed,  this  treatment  consistently increased  thy- 
mocyte  migration  above  that  of the  control  cultures  by 
"-~25%. Though ot4137 is an alternative FN receptor (40) we 
observed only minimal thymocyte expression and no inhi- 
bition  of migration  with  ACT1,  a  specific blocking mAb 
(data not shown). 
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CFN and CS1  sequences within 
the human thymus. Frozen thy- 
mic sections were stained by in- 
direct immunofluorescence using 
mAbs  specific  for  plasma  FN, 
cellular FN (CFN), and CS1. FN 
and  CFN-specific immunoreac- 
tivity  (upper panels)  is  predomi- 
nantly detected in  large  patches 
within the medulla (m), whereas 
relatively  less  frequent  positive 
structures  are  observed  in  the 
cortex  (cx). CSl-specific  stain- 
ing (lower left panel) reveals a fine 
reticular  pattern,  strongly high- 
hghting the medulla and sharply 
marking  the  cortico-medullary 
junction. Sparse  CS1 positive ar- 
eas are also  observed in the cor- 
tex. The star identifies a Hassal's 
corpuscle. The lower right panel 
represents a section stained with 
a control IgM and secondary re- 
agents. Similar background levels 
of  fluorescence  were  observed 
using control IgGs (not shown). 
Bar, 22 ~tm, 
Figure 6.  Time-lapse video microscopy ofthymocyte migration. Thymocytes migrating over a period of 8 h through Transwell  TM  membranes coated 
with 0.2 Ixg/ml of FN were labeled with the red fluorescent carbocyanine Dil, whereas thymocytes that remained in the upper chamber were labeled 
with the green fluorescent carbocyanine DiO. The two cell populations were then mixed at a 1:2 ratio and cultured on a glass microwell precoated with 
FN (0.2 ~g/ml). Images were collected for both fluorochromes every 70 seconds for two consecutive periods of  2.5 h. The migratory activity of  red- and 
green-labeled cell populations was first recorded in the presence of control mouse IgG (10 ~g/ml) for 2.5 h (A). Anti-VLA4 and VLA5 mAbs (10 Ixg/ml) 
were then added to the well and cell migration recorded for additional 2.5 h  (/3). The migratory paths traced by individual thymocytes were obtained by 
projecting 130 images using the NIH Image software. In the presence of control lgG, cells from the lower chamber are observed to trace longer paths 
than those displayed by cells from the upper chamber. All migrating cells show a similar direction of movement. Addition of anti-VLA4 and anti-VLA5 
mAbs arrests the migration of the majority of thymocytes. The few cells which are not inhibited display randomly oriented paths of  migration. 
221  Crisa et al. A 
Mouse IgG 
anti-VLA5 mAb 
anti-VLA4 mAb 
anti-VLA4 + VLA5 mAbs 
P66 
P96 
I 
g  g  g 
Migrating ceils (% of control) 
B 
Mouse IgG 
anti-VLA5 mAb 
anti-VLA4 mAb 
anti-VLA4 + 
anti-VLA5 mAbs 
(30 x 104) 
10%  80% 
(24 X 104) 
10% |  78% 
k  ~'!:"  :;i 
./;i:  . % 
('J8 X 104) 
26%  52% 
(3.5 X 104)  i  32%  48% 
￿9  ~'"~=~: 
￿9  .' ~,  .  -  ,;~4:. 
,:,,'..~.:....;  '  ".'.;a.- 
--  CD8 
Subsets 
CD4+CDS+ 
CD8+ 
CD4+ ~ 
CD4+CD8+ 
CD8  + 
CD4+CD8+ L 
CD8  + 
CD4  + 
Migrating  Cells {% of control) 
Figure  4.  Thymocyte migration on intact FN involves engagement of 
the integrins VLA4 and VLA5. (A) Cooperatve signaling by VLA4 and 
VLA5 mediates thymocyte migration. Thymocytes were allowed to mi- 
grate across porous Transwell  TM  membranes coated with FN (10 Izg/ml) 
in the presence of 10 b~g/ml  of the indicated antibodies or peptides. Cells 
migrating to the lower chamber of the Transwells  TM  by 8 h were har- 
vested and counted. Results are expressed as percentage of migrating cells 
in the control experimental conditions (e.g., 100 ￿  [no. of cells migrating 
in the presence of specific blocking Abs or peptide/no,  of cells migrating 
in the presence of control mouse lgG or peptide]). Bars represent the 
mean + SEM of four experiments. (/3) Characterization of thymic subsets 
migrating in the presence or absence of anti-VLA4 and/or anti-VLA5 
mAbs. Thymocytes were allowed to migrate across Transwell  TM  mem- 
branes coated with FN (10 p,g/ml) in the presence of control mouse IgG 
or anti-integrin  mAbs. After 8 h,  thymocytes which  migrated to  the 
lower chamber were harvested, counted and analyzed by flow cytometry. 
The expression of CD4 and CD8 is shown in the dot plots and percent- 
ages of single positive and double positive subsets are indicated in the ap- 
propriate quadrants. Total number of thymocytes migrating in the differ- 
ent experimental conditions are shown in parentheses on top of dot plots. 
Fig.  4  B  shows  a  FACS  |  analysis representative of five 
similar experiments comparing the  CD4/CD8  phenotype 
of thymocytes  migrating  in  the  presence  or  absence  of 
anti-cx4 and anti-~x5 mAbs. We found that blocking VLA4 
alone has little or no effect on the migration of either CD4 
or CD8 single positive thymocytes. On the other hand, the 
anti-~4 mAb inhibits the migration of double positive cells 
by ~"60%.  Three color immunofluorescence  revealed that 
this latter subset comprises thymocytes expressing interme- 
diate levels of CD3 (data not shown). The anti-~x5 mAb in- 
hibited the migration of all three subsets by ~20% (Fig. 4/5'). 
In contrast,  blocking both VLA4 and VLA5  inhibited the 
migration of the CD4 single positive by 64% and the CD8 
single positive by 85%. This treatment also inhibited migra- 
tion of~90%  double positive cells (Fig. 4 B). 
The results indicate that the VLA4 and VLA5 integrins 
play a major role in thymocyte migration on FN. In partic- 
ular, the higher migratory efficiency of single positive thy- 
mocytes on this substrate appears to reflect the engagement 
and  cooperative signalling of both  receptors.  Conversely, 
the double positive thymocytes contain two distinct popu- 
lations defined by their use of VLA4 and VLA5. The mo- 
tility of one  population,  expressing intermediate levels of 
CD3,  is  preferentially mediated  by  VLA4  alone,  while  a 
second  population,  comprising  mostly  CD3  hi  cells,  uses 
both integrins. 
FN Binding Sites  for  VLA 4 and  VLA5-mediated  Cell Mi- 
gration.  The medulla of the human  thymus is highly en- 
riched for FN relative to the cortex, particularly a form of 
FN containing the alternatively spliced CS1 site. However, 
other  sites  exist on  FN  which  can  be  engaged by VLA4 
(14, 41-43). To specifically determine the FN binding sites 
used by migrating thymocytes we tested two non-overlap- 
ping 40- and 120-kD chymotryptic fragments (13) for their 
ability to  support migration.  The  40-kD  fragment  of FN 
contains the CS1 peptide sequence for VLA4, but lacks the 
R.GDS binding site for VLA5 (18). Conversely, the 120-kD 
fragment  comprises  only  the  RGDS  binding  site  recog- 
nized by VLA5 (44). 
As shown  in Fig. 5  A, migration of thymocytes on  the 
40-kD fragment of FN was almost completely inhibited by 
anti-~x4  mAb  and  not  affected  by  anti-~5  mAb.  The 
VLA4-specific blocking peptide,  P96,  but not  the control 
P66,  also  inhibited  migration,  although  less  effectively. 
These differences in the inhibitory effect of blocking mAbs 
and peptides on  [31  integrins are consistent with previous 
reports (45-47). Thymocyte migration on the 120-kD frag- 
Bar graphs represent the quantitative analysis  of thymic subsets migrating 
in  each experimental condition.  They  were  derived by calculating for 
each subset the absolute number of cells which migrated in the presence 
of anti-integrin mAbs; these values were then expressed as percentage of 
the cell number calculated for the same subsets in the control culture. 
About  60%  of migratory double positive thymocytes are inhibited by 
anti-VLA4 mAb alone, whereas blocking of both VLA4 and VLA5 is re- 
quired to inhibit migration of single positive subsets. Similar results were 
consistently observed in five separate experiments 
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Figure 5.  Inhibition ofthymocyte migration on the 40- (A) and 120-kD 
(B) chymotryptic fragments of FN. Thymocyte were allowed to migrate 
on Transwell  TM  membranes coated with the 40- or the 120-kD fragments 
of FN (10 Ixg/ml) containing the CS1  and B.GDS binding sites, respec- 
tively. Migration assays were performed in the presence of 10 I.Lg/rnl of 
either control mouse IgG, anti-VLA5 and/or anti-VLA-4 mAbs, or pep- 
tides P66 and P96 (A). In addition, a mAb blocking the R.GDS cell bind- 
ing site of FN (mAb 333) was used in migration experiments performed 
on the 120-kD fragment (B). After 8 h, cells which migrated in the lower 
chamber were counted and data expressed as % of the cells migrating in 
control cultures. Bars represent the means +  SEM of four (/t) and three 
(B) separate experiments. 
ment was inhibited by N50% using the anti-or5 but not the 
anti-or4 mAb (Fig.  5 B). In fact, when we coated the wells 
with  an  equimolar mixture  of the  120-  and  40-kD  frag- 
ments we  could  demonstrate  the  nearly  complete inhibi- 
tion of migration as observed with the intact FN (data not 
shown). Migration was also inhibited by an anti-FN mAb, 
clone 333,  which binds a site just proximal to the ILGDS 
site and blocks cell binding (37).  Thus, thymocytes appear 
to use the two primary binding sites on FN, CS1 for VLA4 
and RGDS for VLA5.  The partial inhibition of migration 
obtained by blocking VLA5  on the  120-kD  fragment of 
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FN suggests that in the absence of a VLA4-mediated signal 
thymocyte migration  may be  mediated  by an  alternative 
mechanism. 
Analysis of Thymocyte Migration by  Time Lapse Video Mi- 
croscopy.  Time lapse video microscopy has several advan- 
tages for the investigation of cell migration. It permits the 
measurement of migration velocity for a single cell  or sub- 
populations. In addition, it reveals the characteristics of mi- 
gration with respect to direction, persistence of movement 
and the effects of blocking specific receptors. We separated 
thymocyte subpopulations  demonstrating  different  migra- 
tion activities using the Transwell  TM  migration assay.  The 
more motile single positive and double positive thymocytes 
that segregate in the lower chamber were labeled with the 
red fluorescent dye DiI while the less motile double posi- 
tive cells  that remain in  the  upper chamber were labeled 
with the  green fluorescent dye DiO.  The two thymocyte 
subsets  isolated  by  this  means  witl  be  referred  to  as  LC 
(lower chamber) and UC  (upper chamber)  cells.  The two 
labeled subsets were then combined in a single FN coated 
well to study the migration of both subsets simultaneously. 
Fig. 6 A  shows the migration paths followed by individ- 
ual LC (red)  and UC (green) thymocytes over an observa- 
tion  period  of 2.5  h.  These  results  are  representative  of 
three experiments. Most LC thymocytes traced long paths 
across  the  entire  field  of observation.  In contrast,  a  large 
number of UC ceils made only limited movements around 
the point of initial binding to FN as evidenced by a blur- 
ring of the individual cell profiles as compared to the time 
0 image. Although some UC cells were seen to migrate in 
this assay,  they demonstrated shorter migration paths  than 
those typical of the LC cells (mean distance covered within 
the field of observation -+ SEM; UC cells =  224 Ixm +  27; 
LC cells  =  379  Ixm +  41;  P  =  0.005).  The persistence of 
cell movement is another characteristic of migrating cells. 
Video  analysis  of  serial  images,  revealed  that  LC  cells 
moved continuously, whereas UC cells were often pausing 
or arresting their movement during the observation period. 
This distinct behavior correlated with the significant differ- 
ence in path lengths displayed by the two populations. Fi- 
nally, determination of mean migration velocities revealed 
a value of 9.6  +  1.8  ixm/min for the LC cells  and 7.2  -+ 
0.9 Ixm/min for the UC cells (P =  NS). 
A consistent observation in this series of experiments was 
that  mobile  cells  of either  subset  maintain  a  similar  and 
constant direction of movement (Fig.  6 A, bottom panel). 
To  determine  the  effect of blocking the  interaction  with 
FN we added both anti-or4 and anti-o~5  mAb to the cul- 
tures.  These antibodies  abruptly arrested the  migration of 
the  majority  of thymocytes  (Fig.  6  B).  Interestingly,  the 
few cells whose migration was not inhibited lose their orig- 
inal  direction  of movement and  traced parabolic paths  in 
random directions (Fig. 6 B, bottom panels). 
Discussion 
In the present study we demonstrate that the interaction 
of CD3  hi double positive and single positive ceils with FN signals  migration of these more mature  thymocytes. Fur- 
thermore, the amount ofligand regulates thymocyte motil- 
ity such that at low concentrations of FN the migration of 
the most mature thymocytes is favored, whereas higher FN 
concentrations are  required to  promote the  migration  of 
less  mature  cells.  The differential distribution  of FN  and 
CS1 binding sites that we document in the thymic medulla 
and cortex indicates that the expression and density of this 
ligand  is  in  fact  regulated  in  vivo,  thereby  providing  a 
mechanism for controlling thymocyte migration between 
these two compartments. Finally, thymocyte migration in- 
volves engagement of both VLA4 and VLA5  to the  CS1 
and  IkGDS  sequences  of FN  and both  receptors are  in- 
volved in maintaining the persistence and directionality of 
cell movement. Our results  provide strong evidence for a 
FN/integrin-mediated pathway regulating thymocyte mo- 
tility at the transition from the double positive to the single 
positive stage of maturation. 
We  have  previously identified a  unique  population  of 
immature CD31~ double positive thymocytes characterized by 
firm adhesion to FN via VLA4 and proposed that VLA4/FN 
interactions regulate the  positioning of immature thymo- 
cytes within the cortex (34). Indeed our present data dem- 
onstrate  that  thymocytes  enriched  for  the  more  mature 
CD3 hi single positive and double positive cells migrate at 
high efficiency on FN, whereas most immature CD31~  dou- 
ble positive cells appear to he stationary. Taken together, 
the  adhesive  and  migratory  characteristics  of CD31~ and 
CD3  hi thymic subsets suggest that cells which adhere avidly 
to FN (i.e., CD31~ double positive cells) are unable to mi- 
grate, whereas those establishing low levels of adhesion to 
this substrate are motile. Human hematopoietic progenitors 
also demonstrate a selective interaction with FN such that 
the earliest colony-forming unit (CFU) cells are firmly ad- 
herent and lose this property with maturation (48). Similar 
results  have been reported for bone marrow progenitors of 
the erythroid and B  cell lineages (46,  49). However, these 
studies have only inferred that the biological significance of 
this loss of adhesion is the initiation of migration. Here we 
demonstrate that FN can provide both anchorage and mi- 
gratory cues for thymic subsets  at distinct stages of matura- 
tion. Thus, the regulation of both adhesion and migration 
to FN may be a conserved mechanism determining the po- 
sition of developing progenitor cells and the subsequent re- 
lease  of their  mature  progeny from various  hemopoietic 
compartments. 
We observed that the migratory activity of thymocytes is 
influenced by the  concentration of ligand.  Compared  to 
the migration observed on low concentrations of FN, higher 
concentrations of surface-bound FN induced a 10-15-fold 
increase in the number of migrating double positive and a 
3-4-fold increase in single positive thymocytes. A  similar 
site density-dependent efficiency of migration on FN has 
been documented for T  lymphoblastoid cell lines (47),  in- 
dicating  that  this  phenomenon  may  regulate  motility. 
Moreover,  analysis  of integrin  expression comparing the 
migrating  to  the  non-migrating  cells  (Table  1)  demon- 
strates  that cells migrating on relatively low concentrations 
of FN  are  enriched  for  single  positives  expressing  only 
slightly less VLA4 than the  non migrating population.  In 
contrast, on the highest concentration of FN  (5  Ixg/ml) a 
double  positive  population  is  recruited  to  migrate  with 
higher levels of VLA4 than the non-migrating ceils. Thus, 
receptor expression levels, alone, do not determine the dif- 
ferences in  cell migration  or adhesion.  This  is  consistent 
with the current understanding that integrin function is the 
net effect of receptor expression level and receptor activity 
(30-33). 
These data for migration on different concentrations of 
FN have two implications. First, they suggest that while the 
migratory capability of a given cell on FN depends on its 
maturation  state,  the  amount  of FN  present  in  the  mi- 
croenvironment determines the efficiency of cell movement. 
In this context, capability refers to the intrinsic potential of 
a  given cell to migrate,  whereas  efficiency represents the 
actual migration of the cell in response to a ligand. Second, 
migration  determined by  different  concentrations  of FN 
defines at least three  functionally distinct double  positive 
thymic  populations:  (a)  CD3hiCD69  hi  migrating  on  low 
concentrations, (b) CD3intCD69 int recruited by higher con- 
centrations and (c) CD31~176  which do not migrate 
at all under these experimental conditions. Notably, double 
positive thymocytes which can be recruited to migrate by 
increasing amounts of FN, have the same intermediate lev- 
els of CD3 and MHC class I as the non-migratory double 
positive  cells.  However,  they  are  distinguished  by  the 
higher levels of CD69. This result suggests that thymocytes 
may acquire the potential to migrate at a stage  in double 
positive development marked by increased levels of expres- 
sion of the activation marker CD69  (50).  Overall, the data 
indicate  that  single  positive  and  double  positive  thymic 
subsets,  otherwise relatively homogeneous for phenotype, 
are in fact functionally heterogeneous populations with re- 
spect to their migratory activity. 
The predominant distribution of FN in the medulla of 
the human  thymus is  consistent with previous reports  (5, 
51). We also present the novel finding that the medulla is 
highly  enriched  for  an  alternatively spliced  form  of FN 
containing the CS1  cell binding site.  In light of our func- 
tional  studies  demonstrating  the  regulation  of thymocyte 
migration by ligand concentrations and the requirement for 
binding to both the 1<GDS and the CS1  site,  this  pattern 
suggests  that FN might in fact control the migratory effi- 
ciency of developing thymocytes in vivo. The lower abun- 
dance of FN and CS1  sites in the cortex would favor the 
stationary  phenotype  of immature  double  positive  thy- 
mocytes preventing their premature movement to the me- 
dulla.  Conversely, the high abundance of CSl-containing 
FN  in  the  medulla  may facilitate migration  of the  more 
mature  single  positive  cells  into  this  compartment  and 
eventually export to the periphery. In addition, it may also 
provide a microenvironment favorable to the recirculation 
of peripheral T  cells and entry of antigen-presenting cells 
into the medulla (4). 
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thymocyte migration,  we  do  not  exclude  the  possibility 
that other mechanisms regulate the movement of develop- 
ing cells from one thymic compartment to another in vivo. 
VCAM-1  is  an  alternative ligand  for VLA4  and  supports 
adhesion with substantially higher avidity than FN (22, 52). 
We have recently demonstrated that VCAM-1  is expressed 
by thymic epithelial cells in the cortex and that this ligand 
mediates the adhesion of immature double positive thymo- 
cytes to thymic epithelial cells (Salomon,  D.1L., L. Crisa, C.F. 
Mojcik, J.K.  Ishii,  G. Klier, and E.M.  Shevach, manuscript 
submitted for publication). These data suggest that the inter- 
action between VLA4 and VCAM-1  may be an alternative 
adhesive pathway anchoring immature thymocytes within 
the cortex. On the other end, studies in rodents have de- 
termined that the residency of single positive thymocytes in 
the  medulla may be  quite long,  ranging from  1  to  2  wk 
(53).  During  this  time  thymocytes acquire  the  ability  to 
produce cytokines (54)  and proliferate in response to anti- 
gen  stimulation  (55).  Interactions  holding  thymocytes in 
the medulla are therefore crucial to the completion of these 
differentiation steps.  Certain cytokines may influence lym- 
phocyte motility (56).  It has been shown that CD2/LFA-3 
and LFA-1/ICAM-1  adhesive interactions may also be in- 
volved in thymocyte differentiation (57,  58).  Interestingly, 
we observed that thymocyte migration on FN is enhanced 
by the addition  of an antibody blocking ICAM-1.  These 
results  suggest that cell-cell interactions mediated by alter- 
native  pairs  of adhesion  molecules  such  as  LFA-1  and 
ICAM-1  may be  one molecular mechanism  counter-bal- 
ancing thymocyte motility. 
The  migration  of CD4  and  CD8  single  positive  thy- 
mocytes is mediated by a cooperative interaction between 
VLA4 and VLA5. In contrast, a substantial fraction (~60%) 
of the  mobile  double positive thymocytes appears  to  use 
only VLA4 for migration.  These double positive cells  are 
relatively immature (e.g., CD3  int) and have the same phe- 
notype as those which can be "recruited" to migrate on in- 
creasing  amounts  of FN.  These  data suggest that  a  func- 
tional modulation of VLA4 from a highly adhesive to a less 
adhesive state may be the earliest event initiating migration 
at the double positive stage.  However, this mechanism may 
not be very efficient at promoting migration as it requires a 
high  density  of ligand.  Ultimately,  the  high  efficiency of 
migration exhibited by single positive thymocytes may re- 
flect the upregulation of VLA5 at this later stage  of devel- 
opment (34,  35 and Table 1) and the engagement of both 
VLA4 and VLA5. A  similar cooperation of these integrins 
in mediating cell movement has been reported previously 
for highly motile neural crest cells  (59).  These studies fur- 
ther demonstrated that while binding to CS1  (presumably 
by VLA4)  determines the  speed of migration, binding  to 
RGDS sequences by VLA5 is involved in maintaining the 
direction of migration (59),  a result recently confirmed by 
studies  using ot5-transfected cells  (60).  In  this  regard,  our 
analysis of thymocyte motility by time lapse video micros- 
copy demonstrated that migrating thymocytes follow a per- 
Figure  7.  A  model  integrating  the  roles  of fibronectin,  VLA4  and 
VLA5 in thymocyte migration with the developmental changes occurring 
at the transition from the double positive to single positive stage of  matu- 
ration. 
sistent direction of movement which is disrupted by block- 
ing  VLA4  and  VLA5.  The  data  suggest  that  VLA4  and 
V-LA5/FN interactions determine not only the occurrence 
of cell movement but also signal information for the persis- 
tence and directionality of migration. 
We propose a model in which thymocyte adhesion and 
migration  mediated  by  VLA4  and  VLA5  is  coordinated 
with development in the thymus (Fig.  7).  (a) At the early 
CD3i~176  double positive stage  of maturation, thy- 
mocytes express a form of VLA4 that firmly anchors these 
ceils to FN expressed on cortical epithelium. This binding 
may serve to stabilize TCR./MHC/co-receptor interactions 
during  positive selection.  (b)  Successful positive selection 
signals thymocyte activation marked first by the upregula- 
tion of CD69.  The functional state of VLA4 has changed 
on these cells to the extent that they could be recruited to 
migrate if exposed to high concentrations of FN containing 
the CS1 site.  However, their location in the cortex, which 
is relatively poor in this form of FN, prevents migration at 
this stage.  In parallel,  the majority of double positive cells 
that are not selected at this stage  progressively lose the ca- 
pacity to adhere or migrate using VLA4 and undergo apop- 
tosis.  (c) Further maturation produces a double positive cell 
which  is  CD3hiCD69hiMHC  I  int-hi. These  cells  begin  to 
upregulate VLA5  expression and function  (34,  35)  which 
in collaboration with VLA4 initiates an efficient migration 
on the low concentrations of FN in the cortex. (d) At the 
late  single  positive  stage  of maturation,  thymocytes have 
acquired the highest capacity to migrate by means of VLA4 
and VLA5. The high concentration of FN and CS1 bind- 
ing sites present in the medulla support this activity. While 
it is possible that single positive thymocytes are actively mi- 
grating in the medulla, it is more likely that other interac- 
tions contribute to hold thymocytes at this site and allow 
225  Crisa et al. their differentiation program to  be  completed.  Neverthe- 
less, their high migratory capability should allow them  to 
efficiently exit the medulla when  full maturation is finally 
achieved. 
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